Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Micardis

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Micardis was produced by Boehringer Ingelheim and Astellas.

Boehringer Ingelheim returns to growth after US turnaround

Boehringer Ingelheim returns to growth after US turnaround

Boehringer's heart drug Micardis (telmisartan) continued to suffer the effects of generic competition, with sales down 12.1% to 956m, but 2015 also saw the company's diabetes portfolio making

Humira remains top pharma product, but Sovaldi closes in

Humira remains top pharma product, but Sovaldi closes in Boehringer has seen a similar situation with its heart drug Micardis(telmisartan) that has been losing patent protection for over a year.

Heart drug sales continue downward spiral

Heart drug sales continue downward spiral Finally Boehringer, which saw the largest drop in the top ten table due predominately to the patent loss of Micardis (telmisartan).

Boehringer's sales drop after 'intense and challenging' year

Boehringer's sales drop after 'intense and challenging' year During the year all four of Boehringer's top products saw their global sales decline, most noticeably cardiovascular drug Micardis (telmisartan) and COPD treatment Combivent (ipratropium and albuterol), both of which

Micardis

Micardis campaign. Created by Seven Stones for Boehringer Ingelheim. Therapy area: Cardiovascular

1 2 3 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
11 London

11 London is a strategic and creative agency working in the fields of health and humanity – complex areas, but...

Latest intelligence

Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
Gilead Headquarters
The search for effective drug treatments for COVID-19
PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...

Infographics